Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Saturday, June 21, 2025 · 824,457,610 Articles · 3+ Million Readers

Artificial Intelligence in Drug Screening Market to Set Phenomenal Growth in Key Regions By 2025

Artificial Intelligence in Drug Screening Market

Artificial Intelligence in Drug Screening

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

Artificial Intelligence in Drug Screening Market by Product Type (Immunoassay Analyzers, Breathalyzer, Rapid Test Device, Assay Kits, and Chromatography Instruments), Sample Type (Urine, Hair, Oral)”
— Allied Market Research

NE WIN SIVERS DRIVE, PROVINCE: - PORTLAND, UNITED STATES, November 8, 2021 /EINPresswire.com/ -- According to the report by Allied Market Research, titled, "Artificial Intelligence in Drug Screening Market by Product Type (Immunoassay Analyzers, Breathalyzer, Rapid Test Device, Assay Kits, and Chromatography Instruments), Sample Type (Urine, Hair, Oral, and Others), and End User (Workplace, Criminal Justice, and Hospital): Opportunity Analysis and Industry Forecast, 2018 - 2025". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Artificial intelligence (AI) is an area of computer science that emphasizes on the creation of intelligent computers to perform tasks like humans. Artificial intelligence offers activities such as speech recognition, learning, planning, problem solving, and others. It can also be applied in the field of drug screening. Drug screening is a process of chemical analysis designed to test patients for drug abuse. It is a vital process as drug abuse is a serious public health problem that affects brain and behavior of an individual. This process is also employed in workplaces to avoid hiring of drug addict candidates and to provide a safe workplace to other employees. Artificial intelligence has made it possible to screen drug abuse candidates in shorter period, moreover it also plays a great role in treatment of patients with drug addiction.

(A PDF | Sample Of The Report Is Available Immediately Upon Request) @ https://www.alliedmarketresearch.com/request-sample/5236

List of Key Players Profiled in the Report

Alere, Inc.
Drgerwerk AG & Co. KGAA
Abbott Laboratories
Hoffmann-La Roche AG
Biorad Laboratories, Inc.
Siemens AG
Thermo Fisher Scientific, Inc.
Danaher Corporation
Quest Diagnostics Incorporated
Express Diagnostics International Inc.

Covid-19 Scenario:

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

Detailed COVID-19 Impact Analysis on Market: https://www.alliedmarketresearch.com/request-for-customization/5236?reqfor=covid

Key Benefits For Stakeholders:

1) The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

2) It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

3) The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.

4) A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.

Frequently Asked Questions?

Who are the leading market players active in Artificial Intelligence in Drug Screening Market?
What are the current trends that will influence the market in the next few years?
What are the driving factors, restraints, and opportunities in Artificial Intelligence in Drug Screening Market?
What are the projections for the future that would help in taking further strategic steps?

Make Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/5236

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published a few syndicated market studies in a similar area that might be of your interest. Below is the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of a pandemic on short-term and long-term growth trends of this market.”

Trending Upcoming Reports in Healthcare Industry (Book Now with 10% Discount):

Glucose Tolerance Test Market – Opportunity & Industry Forecast, 2030
Multivitamin Supplements Market – Opportunity & Industry Forecast, 2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry, Science

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release